Technologies for Microbiome Science
4.00-4.30 Dr Rupasri Mandal; University of Alberta, Canada.
“The Metabolomics Innovation Centre (TMIC) – Comprehensive and Quantitative Metabolomics”
4.30-5.00 Ian MacLaren; Oxford Nanopore Technology, UK
Dr Rupasri Mandal (Senior Research Associate/Facility Manager of TMIC) received her PhD in environmental analytical chemistry from Carleton University, Ottawa, Canada, in 2001. Her research experience is broad and covers the field of metabolomics, bioanalytical, biomedical, environmental/analytical and physical chemistry. She has >15 years of research/work experience in these fields. Over this period of time, she has gained an extensive experience in the development of novel schemes and analytical/bioanalytical techniques for targeted and untargeted metabolomics, to study drug-protein interactions and for chemical speciation and bioavailability of potentially toxic trace metals in freshwaters. In addition, she has mastered in the operation and general maintenance of various analytical tools such as GC-MS, LC-MS, ICP-MS, HPLC, UPLC and several sample preparation equipment. She is also well acquainted with the univariate and multivariate statistical software for metabolomics data interpretation.
In the past, she has worked as Project Coordinator/Manager for the Human Biomonitoring Project and PAN-Alberta Metabolomics Platform (PANAMP) at University of Alberta, Canada. Since 2011 she is working as the Facility Manager for The Metabolomics Innovation Centre (TMIC), which is Canada’s national metabolomics laboratory. TMIC, which was launched in 2011, has >$12 million of equipment and a staff of 20 highly trained scientists who are capable of performing a wide range of fully quantitative metabolomic assays using NMR, GC-MS, LC-MS and ICP-MS methods. TMIC typically analyzes >5000 samples a year and performs more than 20,000 metabolomic assays a year. As TMIC facility manager, she is responsible for coordination and management of TMIC operations and technology developments. These activities include, but are not limited to developing and implementing the strategic plan for research activities; designing experiments, research methods, data collection protocols, and standards in consultation with the Director; managing TMIC’s facility personnel and their activities; identifying and reporting on new metabolomic technologies, coordinating and conducting the development and adaptation of new metabolomic technologies; training new staff on how to properly use TMIC equipment; communicating with TMIC clients, analyzing/interpreting metabolomic data and preparing reports for clients; assisting TMIC directors with the preparation of grants, contracts and scientific publications, budget planning, equipment and supply purchases. Complete List of Published Work: https://scholar.google.ca/citations?user=888iXEgAAAAJ&hl=en
Ian MacLaren Studied molecular genetics at both Glasgow and Oxford Universities before working in the commercial teams of Invitrogen, Sigma, and Cellectricon. Spent the last 8 years working for the global market leader in genomics technology (Illumina), primarily focussed on the introduction of genomics into routine agricultural testing. Joined Oxford Nanopore Technology this year with a focus on deploying nanopore’s highly innovative and disruptive new technology in the fields of agriculture and food.
Date/Time Date(s) - Nov 16 2017 4:00 pm - 5:30 pm
University College Cork West Wing 6